Table 1.
Clinical characteristics of PDAC and non-cancer subjects.
| Subject case # | Status | Gender | 1Race | Age | Stage | 2Grade | 3LNM | 4DM |
|---|---|---|---|---|---|---|---|---|
| PC1 | PDAC | M | CA | 52 | IIA | G2 | N | N |
| 001 | Non-cancer | F | AA | 33 | NA | NA | NA | NA |
| 002 | Non-cancer | F | CA | 29 | NA | NA | NA | NA |
| 003 | Non-cancer | F | AA | 29 | NA | NA | NA | NA |
| PC2 | PDAC | M | AA | 71 | IIA | G2 | N | N |
| PC3 | PDAC | M | AA | 75 | IIB | G2 | Y | N |
| 004 | Non-cancer | F | CA | 49 | NA | NA | NA | NA |
| PC4 | PDAC | F | CA | 74 | IIA | G2 | N | N |
| 005 | Non-cancer | F | CA | 46 | NA | NA | NA | NA |
| PC5 | PDAC | M | CA | 73 | IIA | G3 | N | N |
| 006 | Non-cancer | F | CA | 56 | NA | NA | NA | NA |
| PC6 | PDAC | F | AA | 67 | IIB | G3 | Y | N |
| 007 | Non-cancer | F | CA | 27 | NA | NA | NA | NA |
| PC7 | PDAC | M | CA | 67 | IIB | G3 | Y | N |
| 008 | Non-cancer | F | AA | 46 | NA | NA | NA | NA |
| PC8 | PDAC | M | CA | 62 | IIA | G2 | N | N |
| 009 | Non-cancer | F | CA | 28 | NA | NA | NA | NA |
| PC9 | PDAC | F | AA | 72 | III | NA | Y | N |
| 010 | Non-cancer | F | CA | 33 | NA | NA | NA | NA |
| PC10 | PDAC | M | AA | 81 | III | NA | N | N |
| PC11 | PDAC | M | AA | 53 | IV | NA | NA | Y |
| PC12 | PDAC | M | AA | 47 | IV | NA | Y | Y |
| PC13 | PDAC | F | CA | 58 | IV | G2 | NA | Y |
| PC14 | PDAC | M | CA | 77 | IV | G2 | NA | Y |
| PC15 | PDAC | M | CA | 60 | IV | G2 | NA | Y |
| PC16 | PDAC | F | CA | 71 | IV | G3 | NA | Y |
| PC17 | PDAC | M | AA | 64 | IV | G3 | NA | Y |
| PC18 | PDAC | F | AA | 48 | IV | G2 | N | Y |
| PC19 | PDAC | M | CA | 70 | IV | G2 | NA | Y |
| PC20 | PDAC | F | AA | 65 | IV | G3 | N | Y |
1AA, African American, 1CA, Caucasian American. 2G2, moderately differentiated; G3, Poorly differentiated; NA, Not available. 3LNM, Lymph node metastasis; Y, Yes; N, No; NA, Not available. 4DM, Distant metastasis; Y, Yes; N, No.